All tenders
75N98026P01477

MODIFICATION TO THE A11 HERV-E TCR AND T CELL PRODUCT TOIMPROVE THE THERAPEUTIC EFFICACY FOR CCRCC PATIENTS

National Institutes of Health · United States

This contract has been awarded. Browse open opportunities
View Source

Time Left to Bid

Awarded

AwardedEducation & TrainingFederal

Basic information

Reference number
75N98026P01477
Government level
Federal
Solicitation type
Education & Training
Title
MODIFICATION TO THE A11 HERV-E TCR AND T CELL PRODUCT TOIMPROVE THE THERAPEUTIC EFFICACY FOR CCRCC PATIENTS
Source ID
usa-75N98026P01477

Details

Location
United States

Description

MODIFICATION TO THE A11 HERV-E TCR AND T CELL PRODUCT TOIMPROVE THE THERAPEUTIC EFFICACY FOR CCRCC PATIENTS Awarded to: LOYOLA UNIVERSITY OF CHICAGO Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: PURCHASE ORDER

Dates

Publication
2026/09/15 12:00:00 AM UTC
Closing date
2027/09/14 12:00:00 AM UTC

Estimated value

$350K USD

Classification

Normalized category

Education & Training

Source: USASpending (Federal)

Last updated 2026-09-15, 11:39:55 a.m.

Data refreshed every 2 hours